Synaptogenix, Inc. (SNPX)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
SNPX Insider Trading Activity
SNPX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About Synaptogenix, Inc.
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; …
Insider Activity of Synaptogenix, Inc.
Over the last 12 months, insiders at Synaptogenix, Inc. have bought $0 and sold $0 worth of Synaptogenix, Inc. stock.
On average, over the past 5 years, insiders at Synaptogenix, Inc. have bought $165,600 and sold $190,375 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $83,000 was made by Silverman Joshua (director) on 2021‑06‑14.
List of Insider Buy and Sell Transactions, Synaptogenix, Inc.
| 2022-12-16 | Sale | Silverman Joshua | director | 19,012 0.2656% | $1.17 | $22,280 | -30.83% | |
| 2022-12-16 | Sale | Alkon Daniel L. | President and CSO | 19,688 0.2751% | $1.17 | $23,072 | -30.83% | |
| 2022-12-16 | Sale | WEINSTEIN ROBERT | Chief Financial Officer | 27,000 0.3773% | $1.17 | $31,641 | -30.83% | |
| 2022-12-16 | Sale | TUCHMAN ALAN J | Chief Executive Officer | 27,000 0.3773% | $1.17 | $31,641 | -30.83% | |
| 2022-12-16 | Sale | Singer William S. | director | 27,000 0.3773% | $1.17 | $31,641 | -30.83% | |
| 2022-12-16 | Sale | SCHECHTER JONATHAN | director | 20,250 0.2829% | $1.17 | $23,731 | -30.83% | |
| 2022-12-16 | Sale | Bernstein Bruce | director | 22,500 0.3144% | $1.17 | $26,368 | -30.83% | |
| 2021-06-14 | Silverman Joshua | director | 10,000 0.2577% | $8.30 | $83,000 | -3.58% | ||
| 2021-06-14 | Alkon Daniel L. | Chief Scientific Officer | 10,000 0.2565% | $8.26 | $82,600 | -3.58% |
Insider Historical Profitability
| Silverman Joshua | director | 38238 2.8207% | $107,066.40 | 1 | 1 | <0.0001% |
| Alkon Daniel L. | President and CSO | 35546 2.6221% | $99,528.80 | 1 | 1 | <0.0001% |
Historical Insider Profitability vs. Competitors
$18,881,323 | 88 | -48.96% | $5.9M | |
$296,936 | 37 | -18.12% | $3.46M | |
$960,082 | 17 | -6.29% | $3.37M | |
$1,558,469 | 16 | -26.98% | $4.79M | |
$139,855 | 11 | -32.84% | $5.37M |
SNPX Institutional Investors: Active Positions
| Increased Positions | 2 | +28.57% | 12,995 | +510.81% |
| Decreased Positions | <1 | -14.29% | 1,005 | -39.5% |
| New Positions | <1 | New | 10,844 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 8 | +14.29% | 14,534 | +471.31% |
SNPX Ownership Change vs Market
Institutional Investor Ownership
| Geode Capital Management, Llc | $29.00 | 1.08% | 10,844 | +10,844 | New | 2024-12-31 |
| Ubs Group Ag | $9.00 | 0.32% | 3,238 | +2,151 | +197.88% | 2024-12-31 |
| Tower Research Capital Llc (Trc) | $1.00 | 0.03% | 266 | -1,005 | -79.07% | 2024-12-31 |
| Morgan Stanley | $0 | 0.01% | 90 | 0 | 0% | 2024-12-31 |
| Osaic Holdings, Inc. | $0 | <0.01% | 34 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $0 | <0.01% | 29 | 0 | 0% | 2024-12-31 |
| Acadian Asset Management Llc | $0 | <0.01% | 23 | 0 | 0% | 2024-12-31 |
| Bank Of America Corp /De/ | $0 | <0.01% | 10 | 0 | 0% | 2024-12-31 |